VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Fusion Pioneer GFUZ Cools Off After Nasdaq Debut
Value Add VC/Pulse/IPO

Fusion Pioneer GFUZ Cools Off After Nasdaq Debut

The first pure-play fusion company to trade on a major exchange has cooled from its debut-day highs as investors settle into valuing pre-revenue fusion technology.

By the Numbers

Jul 13, 2026
Nasdaq debut
$12.80
Debut-day open
$14.85
Debut-day high
$150M
Cash position
~$1.10B
Market cap now
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 24, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

General Fusion began trading on Nasdaq July 13 under ticker GFUZ via merger with Spring Valley Acquisition Corp. III, beating Trump-backed TAE Technologies to market

2

Shares opened at $12.80 and hit an intraday high of $14.85 on debut day before settling into a lower, more volatile range around $13.60 two weeks later

3

The company holds about $150 million in cash to fund its Lawson program toward fusion milestones targeted for 2028, built on more than 200,000 plasma experiments

4

It's now a real-time test case for how public markets price pre-revenue deep-tech, ahead of rivals like TAE Technologies and Commonwealth Fusion Systems

TC

The VC Read · Trace's Take

Trace Cohen

Being first to market as a public fusion company is a flex, but the real story is what happens after the pop fades -- and GFUZ is already fading. Pre-revenue deep-tech investors need to stop celebrating the ticker and start asking whether public markets will actually fund multi-year R&D milestones without panicking every earnings cycle.

IPO Wave 2026 → IPO Scorecard →

Analysis

General Fusion made history on July 13 as the first pure-play fusion energy company to trade on a major exchange, listing on Nasdaq under ticker GFUZ after completing its business combination with Spring Valley Acquisition Corp. III. The debut beat Trump-backed rival TAE Technologies to public markets by several months. Shares opened at $12.80, spiked to an intraday high of $14.85, and traded on nearly 6 million shares of volume on day one.

Two weeks on, the stock has cooled from that debut-day enthusiasm, recently trading around $13.60 with a market capitalization near $1.10 billion. General Fusion enters public life with roughly $150 million in cash, which it says will fund its Lawson program through key Magnetized Target Fusion milestones targeted for 2028, built on more than 200,000 plasma experiments and its LM26 demonstration machine.

“Two weeks on, the stock has cooled from that debut-day enthusiasm, recently trading around $13.60 with a market capitalization near $1.10 billion.”

The listing matters beyond one ticker: it's the first live market test of how public investors value a pre-revenue fusion company, at a moment when General Fusion was also ranked first on TIME's Top GreenTech Companies list and signed a fusion-deployment framework agreement in Italy. Competitors including TAE Technologies and Commonwealth Fusion Systems are watching GFUZ's trading behavior closely as they weigh their own paths to public markets.

What to watch: whether GFUZ stabilizes above its IPO reference price as lockups and analyst coverage kick in, and whether its trading pattern encourages or discourages other fusion and deep-tech players from following the SPAC-to-Nasdaq route.

ShareXLinkedInEmail

More on

General Fusion →

Reported by TechCrunch · First reported by StockAnalysis.com · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 7, 2026

SpaceX Swings From Post-Earnings Drop to 16% Rally

Illustration for: SpaceX Swings From Post-Earnings Drop to 16% Rally
IPO$7.81B Q2 revenue

SpaceX Swings From Post-Earnings Drop to 16% Rally

SpaceX stock fell 8% after a Q2 earnings beat spooked investors on capex, then rallied 15.83% three days later as its first lockup expiration passed without heavy selling and the Cursor deal stayed on track.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

IPO· Aug 7, 2026

BofA's Sell Signal Hits Highest Level Since 2021

Illustration for: BofA's Sell Signal Hits Highest Level Since 2021
IPO

BofA's Sell Signal Hits Highest Level Since 2021

Bank of America's Bull & Bear sentiment indicator jumped to 9.7 -- its highest reading since 2021 and above the firm's own 8.0 sell-signal threshold -- even as the S&P 500 and Nasdaq both rallied Friday on weak jobs data.

@Trace_Cohen·t@nyvp.com